Cite
Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
MLA
Pan, Lili, et al. “Tocilizumab Treatment Effectively Improves Coronary Artery Involvement in Patients with Takayasu Arteritis.” Clinical Rheumatology, vol. 39, no. 8, Aug. 2020, pp. 2369–78. EBSCOhost, https://doi.org/10.1007/s10067-020-05005-7.
APA
Pan, L., Du, J., Liu, J., Liao, H., Liu, X., Guo, X., Liang, J., Han, H., Yang, L., & Zhou, Y. (2020). Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis. Clinical Rheumatology, 39(8), 2369–2378. https://doi.org/10.1007/s10067-020-05005-7
Chicago
Pan, Lili, Juan Du, Jiayi Liu, Hua Liao, Xiaoli Liu, Xi Guo, Jing Liang, Hongya Han, Lixia Yang, and Yujie Zhou. 2020. “Tocilizumab Treatment Effectively Improves Coronary Artery Involvement in Patients with Takayasu Arteritis.” Clinical Rheumatology 39 (8): 2369–78. doi:10.1007/s10067-020-05005-7.